8 Articles
8 Articles
Semler Scientific Gets Buy Rating From Benchmark_ $101 Price Target on Bitcoin Treasury Pivot
Benchmark's Mark Palmer initiated coverage of Semler Scientific (SMLR) with a buy rating and a $101 price target, citing the company’s dramatic pivot from medical diagnostics to bitcoin (BTC) accumulation as a key value driver. Semler, which spent over 15 years focused
Beyond the popularity gained in the cryptocurrency sector, Bitcoin corporate cash leads to an increase in the relevant shares. In the field, the company Semler Scientific might well be largely undervalued. The Semler Scientific (SMLR) article: the most promising Bitcoin treasury action? appeared first on Cryptoast.
Semler Scientific Shifts Focus from Artery Disease Screening to Bitcoin Speculation
Semler Scientific, a company previously focused on deve […] The post Semler Scientific Shifts Focus from Artery Disease Screening to Bitcoin Speculation first appeared on GeneOnline News. The post Semler Scientific Shifts Focus from Artery Disease Screening to Bitcoin Speculation appeared first on GeneOnline News.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium